Recombinant Leukotoxoid Technology — Nuplura PH is the first and only cattle vaccine developed in the U.S. market using a combination of outer membrane protein (OMP) and recombinant leukotoxoid technology. Nuplura PH contains consistent levels of leukotoxoid in every dose to provide a strong immune response.
Purified Antigen — Nuplura PH is not a simple, inactivated whole-cell product like most other bacterins. It contains outer membrane proteins that have been extracted and purified through a proprietary process. The result is a reduction of cellular debris, which allows the immune system to focus entirely on critical bacterial components.
Fast Onset of Immunity — Nuplura PH is the only Mannheimia haemolytica vaccine demonstrated to deliver immunity as soon as 10 days.
Minimal Reactivity — The unique formulation of Nuplura PH is gentle on calves. Administered as directed, there should be no effect on the meat or the carcass at slaughter due to injection site reactions.
You will be prompted with product specific questions when you click Add to Cart: